BackGenix Pharmaceuticals Overview

Genix Pharmaceuticals Total Assets

Latest total assets for GENPF: $33K.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$33347.00
↓ 19.98% YoYΔ $-8324.00 vs prior year quarter

Peer trimmed avg / median

Loading

Genix Pharmaceuticals Total Assets History

Loading

Genix Pharmaceuticals vs. peers: Total Assets Comparison

Loading

Genix Pharmaceuticals Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Genix Pharmaceuticals (GENPF) FAQ

As of the most recent data (April 2026), GENPF shows a total assets of $33K. That compares with $42K in the prior-year period — down 20.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GENPF's total assets is now $33K (was $42K) — a 20.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Genix Pharmaceuticals is outperforming or lagging.

Tracking GENPF's total assets over time shows whether Genix Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $33K That compares with $42K in the prior-year period — down 20.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Genix Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $33K) with ownership activity and broader fundamentals.